Bingfan Du

USPTO Granted Patents = 8 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 9.2

ph-index = 4

Forward Citations = 30(Granted Patents)

Company Filing History:

Mersana Therapeutics, Inc.

patents

Years Active: 2010-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11964025 - Peptide-containing linkers for antibody-drug conjugates (2024-04-23),

2. 11135307 - Peptide-containing linkers for antibody-drug conjugates (2021-10-05),

3. 10660901 - Pyrrolobenzodiazepines and conjugates thereof (2020-05-26),

4. 10143695 - Pyrrolobenzodiazepines and conjugates thereof (2018-12-04),

5. 9334269 - Carboxamides as inhibitors of voltage-gated sodium channels (2016-05-10),

6. 9012443 - Bicyclic aryl and heteroaryl sodium channel inhibitors (2015-04-21),

7. 8022221 - Aurora kinase modulators and method of use (2011-09-20),

8. 7776857 - Aurora kinase modulators and method of use (2010-08-17),

Title: Bingfan Du - Pioneering Innovator in Antibody-Drug Conjugates

Introduction: Bingfan Du, a prominent inventor based in Cambridge, MA, has made significant contributions to the field of antibody-drug conjugates. With seven patents under his belt, his work at Mersana Therapeutics, Inc. has revolutionized the development of therapeutics and diagnostics.

Latest Patents: Bingfan Du's latest patents showcase his expertise in peptide-containing linkers for antibody-drug conjugates and derivatives of pyrrolobenzodiazepines. These innovations open new avenues for targeted drug delivery and precision medicine, enhancing the efficacy of treatments for various diseases.

Career Highlights: Bingfan Du's tenure at Mersana Therapeutics, Inc. has been marked by groundbreaking research and development in the realm of biopharmaceuticals. His patent portfolio reflects a deep commitment to advancing the field of antibody-drug conjugates and improving patient outcomes worldwide.

Collaborations: Working alongside esteemed colleagues such as Hanh Nho Nguyen and Holly L Deak, Bingfan Du has fostered a culture of innovation and collaboration within the company. Together, they have driven forward projects that have the potential to reshape the landscape of modern medicine.

Conclusion: In conclusion, Bingfan Du stands out as a visionary inventor whose work continues to push the boundaries of scientific discovery. His dedication to advancing antibody-drug conjugates exemplifies the spirit of innovation that defines the biopharmaceutical industry. With a promising future ahead, Bingfan Du's contributions are set to leave a lasting impact on the world of healthcare.

This text is generated by artificial intelligence and may not be accurate.